Increased number of mature dendritic cells in Crohn's disease: Evidence for a chemokine mediated retention mechanism

Gut

Volumn 55, Issue 2, 2006, Pages 220-227

  Middel, P ^a   Raddatz, D ^a   Gunawan, B ^a   Haller, F ^a   Radzun, H J ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CCL20 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; CELL MATURATION; CELL MIGRATION; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AUTOCRINE COMMUNICATION; CHEMOKINES; CHEMOKINES, CC; COLON; CROHN DISEASE; DENDRITIC CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; MACROPHAGE INFLAMMATORY PROTEINS; MIDDLE AGED; PARACRINE COMMUNICATION; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 30944434828     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.063008     Document Type: Article

References (40)

1. Neurath MF, Schurmann G. Immunopathogenesis of inflammatory bowel diseases. Chirurg 2000;71:30-40.
2. Sartor RB. Innate immunity in the pathogenesis and therapy of IBD. J Gastroenterol 2003;38:43-7.
3. Romagnani P, Annunziato F, Baccari MC, et al. T cells and cytokines in Crohn's disease. Curr Opin Immunol 1997;9:793-9.
4. Stagg AJ, Hart AL, Knight SC, et al. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 2003;52:1522-9.
5. Ikeda Y, Akbar F, Matsui H, et al. Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2001;13:841-50.
6. Bell SJ, Rigby R, English N, et al. Migration and maturation of human colonic dendritic cells. J Immunol 2001;166:4958-67.
7. Page G, Lebecque S, Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: Correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002;168:5333-41.
8. Middel P, Reich K, Polzien F, et al. Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease. Gut 2001;49:795-803.
9. Middel P, Thelen P, Blaschke S, et al. Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease. Am J Pathol 2001;159:1751-01.
10. Luther SA, Tang HL, Hyman PL, et al. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci U S A 2000;97:12694-9.
11. Luther SA, Bidgol A, Hargreaves DC, et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002;169:424-33.
12. Lo JC, Chin RK, Lee YJ, et al. Differential regulation of CCL21 in lymphoid/ nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J Clin Invest 2003;112:1495-505.
13. Columba-Cabezas S, Serafini B, Ambrosini E, et al. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: Implications for the maintenance of chronic neuroinflammation. Brain Pathol 2003;13:38-51.
14. Bonacchi A, Petrai I, DeFranco RMS, et al. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003;125:1060-76.
15. Vassileva G, Soto H, Zlotnik A, et al. The reduced expression of 6Ckine in the pit mouse results from the deletion of one of two 6Ckine genes. J Exp Med 1999;190:1183-8.
16. Gunn MD, Kyuwa S, Tam C, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999;189:451-60.
17. Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99:23-33.
18. Weninger W, Carlsen HS, Goodarzi M, et al. Naive T cell recruitment to nonlymphoid tissues: A role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J Immunol 2003;170:4638-48.
19. Olert J, Wiedorn KH, Goldmann T, et al. HOPE fixation: A novel fixing method and paraffin-embedding technique for human soft tissues. Pathol Res Pract 2001;197:823-6.
20. Fogt F, Zimmerman RL, Ross HM, et al. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep 2004;11:47-50.
21. Kaiserling E. Newly-formed lymph nodes in the submucosa in chronic inflammatory bowel disease. Lymphology 2001;34:22-9.
22. Sartor RB. Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastroenterol 2003;19:358-65.
23. Rogler G. Update in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol 2004;20:311-7.
24. Heller F, Duchmann R. Intestinal flora and mucosal immune responses. Int J Med Microbiol 2003;293:77-86.
25. Hawiger D, Inaba K, Dorsett Y, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med, 2001;194, 769-79.
26. Sallusto F, Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 1999;189:611-14.
27. Sallusto F, Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000;177:134-40.
28. Jonuleit H, Schmitt E, Schuler G, et al. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000;192:1213-22.
29. Dhodapkar MV, Steinman RM, Krasovsky J, et al. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001;193:233-8.
30. Summers KL, Hock BD, McKenzie JL, et al. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am J Pathol 2001;159:285-95.
31. Cravens PD, Lipsky PE. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol Cell Biol 2002;80:497-505.
32. Burgio VL, Fais S, Boirivant M, et al. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 1995;109:1029-38.
33. Krupa WM, Dewan M, Jeon MS, et al. Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. Am J Pathol 2002;161:1815-23.
34. Cyster JG. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med 1999;189:447-50.
35. Cyster JG. Lymphoid organ development and cell migration. Immunol Rev 2003;195:5-14.
36. Katou F, Ohtani H, Nakayama T, et al. Differential expression of CCL19 by DC-Lamp(+) mature dendritic cells in human lymph node versus chronically inflamed skin. J Pathol 2003;199:98-106.
37. Gibejova A, Mrazek F, Subrtova D, et al. Expression of macrophage inflammatory protein-3 beta/CCL19 in pulmonary sarcoidosis. Am J Respir Crit Care Med 2003;167:1695-703.
38. Christopherson KW, Hood AF, Travers JB, et al. Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases. Blood 2003;101:801-6.
39. Weninger W, von Andrian UH. Chemokine regulation of naive T cell traffic in health and disease. Semin Immunol 2003;15:257-70.
40. Kaser A, Ludwiczek O, Holzmann S, et al. Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol 2004;24:74-85.